nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—CYP2C8—Erlotinib—lung cancer	0.107	0.379	CbGbCtD
Mometasone—CYP2C8—Paclitaxel—lung cancer	0.098	0.347	CbGbCtD
Mometasone—CYP2C8—Etoposide—lung cancer	0.0774	0.274	CbGbCtD
Mometasone—CYP2C8—CYP2E1 reactions—CYP2A7—lung cancer	0.00575	0.0409	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—BPTF—lung cancer	0.00523	0.0372	CbGpPWpGaD
Mometasone—Amcinonide—ANXA1—lung cancer	0.00504	0.306	CrCbGaD
Mometasone—CYP2C8—Xenobiotics—CYP2A7—lung cancer	0.00356	0.0254	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—lung cancer	0.00336	0.0239	CbGpPWpGaD
Mometasone—CYP2C8—CYP2E1 reactions—CYP2A6—lung cancer	0.00334	0.0238	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—lung cancer	0.00322	0.023	CbGpPWpGaD
Mometasone—CYP2C8—CYP2E1 reactions—CYP2E1—lung cancer	0.00284	0.0202	CbGpPWpGaD
Mometasone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—lung cancer	0.00263	0.0187	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—RARB—lung cancer	0.0024	0.0171	CbGpPWpGaD
Mometasone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—lung cancer	0.0024	0.0171	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—NKX2-1—lung cancer	0.00228	0.0162	CbGpPWpGaD
Mometasone—Hydrocortisone—ANXA1—lung cancer	0.00212	0.129	CrCbGaD
Mometasone—CYP2C8—Xenobiotics—CYP2A6—lung cancer	0.00207	0.0147	CbGpPWpGaD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP2A6—lung cancer	0.00199	0.0142	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—NODAL—lung cancer	0.00194	0.0138	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—RARB—lung cancer	0.00189	0.0135	CbGpPWpGaD
Mometasone—CYP2C8—Xenobiotics—CYP2E1—lung cancer	0.00176	0.0125	CbGpPWpGaD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP2E1—lung cancer	0.00169	0.0121	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—lung cancer	0.00163	0.0116	CbGpPWpGaD
Mometasone—Dexamethasone—ANXA1—lung cancer	0.00158	0.096	CrCbGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—lung cancer	0.00157	0.0112	CbGpPWpGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—lung cancer	0.00148	0.0105	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.00148	0.0105	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—SOX2—lung cancer	0.00147	0.0104	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.00146	0.0104	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—NPPA—lung cancer	0.00143	0.0102	CbGpPWpGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—lung cancer	0.00141	0.01	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—ATF3—lung cancer	0.00136	0.00967	CbGpPWpGaD
Mometasone—CYP2C8—Xenobiotics—CYP1A1—lung cancer	0.00126	0.00901	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—PTHLH—lung cancer	0.00125	0.00888	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—SFN—lung cancer	0.00122	0.00871	CbGpPWpGaD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP1A1—lung cancer	0.00122	0.00866	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—lung cancer	0.00121	0.0086	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.0012	0.00854	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—lung cancer	0.00113	0.00801	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—APP—lung cancer	0.00111	0.00792	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.00107	0.00763	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IRF1—lung cancer	0.00105	0.00748	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—HPGDS—lung cancer	0.00104	0.00739	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—JUNB—lung cancer	0.00103	0.00732	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—AVP—lung cancer	0.00102	0.0073	CbGpPWpGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—lung cancer	0.000947	0.00674	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.000937	0.00667	CbGpPWpGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—lung cancer	0.000911	0.00648	CbGpPWpGaD
Mometasone—Clobetasol propionate—CYP1A1—lung cancer	0.000909	0.0551	CrCbGaD
Mometasone—NR3C1—Adipogenesis—AHR—lung cancer	0.000896	0.00638	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.00086	0.00612	CbGpPWpGaD
Mometasone—Prednisolone—CYP2A6—lung cancer	0.000852	0.0517	CrCbGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000848	0.00604	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.000812	0.00578	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—HIF1A—lung cancer	0.000812	0.00578	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—lung cancer	0.000802	0.00571	CbGpPWpGaD
Mometasone—Decreased appetite—Vinorelbine—lung cancer	0.0008	0.00143	CcSEcCtD
Mometasone—Conjunctivitis—Docetaxel—lung cancer	0.000799	0.00143	CcSEcCtD
Mometasone—Asthenia—Vinblastine—lung cancer	0.000794	0.00142	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—IL10—lung cancer	0.000794	0.00566	CbGpPWpGaD
Mometasone—Fatigue—Vinorelbine—lung cancer	0.000793	0.00141	CcSEcCtD
Mometasone—Cough—Gemcitabine—lung cancer	0.00079	0.00141	CcSEcCtD
Mometasone—Pain—Vinorelbine—lung cancer	0.000787	0.0014	CcSEcCtD
Mometasone—Immune system disorder—Paclitaxel—lung cancer	0.000787	0.0014	CcSEcCtD
Mometasone—Mediastinal disorder—Paclitaxel—lung cancer	0.000785	0.0014	CcSEcCtD
Mometasone—Epistaxis—Docetaxel—lung cancer	0.000776	0.00138	CcSEcCtD
Mometasone—Asthenia—Topotecan—lung cancer	0.000772	0.00138	CcSEcCtD
Mometasone—Arthralgia—Gemcitabine—lung cancer	0.000771	0.00138	CcSEcCtD
Mometasone—Chest pain—Gemcitabine—lung cancer	0.000771	0.00138	CcSEcCtD
Mometasone—Myalgia—Gemcitabine—lung cancer	0.000771	0.00138	CcSEcCtD
Mometasone—Asthenia—Erlotinib—lung cancer	0.000763	0.00136	CcSEcCtD
Mometasone—Pruritus—Topotecan—lung cancer	0.000761	0.00136	CcSEcCtD
Mometasone—Anaphylactic shock—Irinotecan—lung cancer	0.000759	0.00135	CcSEcCtD
Mometasone—Diarrhoea—Vinblastine—lung cancer	0.000757	0.00135	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000755	0.00538	CbGpPWpGaD
Mometasone—Infection—Irinotecan—lung cancer	0.000754	0.00134	CcSEcCtD
Mometasone—Pruritus—Erlotinib—lung cancer	0.000753	0.00134	CcSEcCtD
Mometasone—Gastrointestinal pain—Vinorelbine—lung cancer	0.000752	0.00134	CcSEcCtD
Mometasone—Back pain—Etoposide—lung cancer	0.000748	0.00133	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—LMNA—lung cancer	0.000743	0.00529	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.000742	0.00528	CbGpPWpGaD
Mometasone—Rhinitis—Docetaxel—lung cancer	0.00074	0.00132	CcSEcCtD
Mometasone—Anaphylactic shock—Gemcitabine—lung cancer	0.000739	0.00132	CcSEcCtD
Mometasone—Diarrhoea—Topotecan—lung cancer	0.000736	0.00131	CcSEcCtD
Mometasone—Infection—Gemcitabine—lung cancer	0.000734	0.00131	CcSEcCtD
Mometasone—Back pain—Paclitaxel—lung cancer	0.000733	0.00131	CcSEcCtD
Mometasone—Pharyngitis—Docetaxel—lung cancer	0.000733	0.00131	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.000731	0.00521	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000731	0.00521	CbGpPWpGaD
Mometasone—Diarrhoea—Erlotinib—lung cancer	0.000728	0.0013	CcSEcCtD
Mometasone—Abdominal pain—Vinorelbine—lung cancer	0.000727	0.0013	CcSEcCtD
Mometasone—Body temperature increased—Vinorelbine—lung cancer	0.000727	0.0013	CcSEcCtD
Mometasone—Anorexia—Irinotecan—lung cancer	0.000723	0.00129	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000721	0.00514	CbGpPWpGaD
Mometasone—Myalgia—Cisplatin—lung cancer	0.000719	0.00128	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—lung cancer	0.000707	0.00503	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CNDP2—lung cancer	0.000705	0.00502	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTM2—lung cancer	0.000705	0.00502	CbGpPWpGaD
Mometasone—Anorexia—Gemcitabine—lung cancer	0.000704	0.00126	CcSEcCtD
Mometasone—Vomiting—Vinblastine—lung cancer	0.000704	0.00126	CcSEcCtD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000697	0.00496	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTM2—lung cancer	0.000695	0.00495	CbGpPWpGaD
Mometasone—Headache—Vinblastine—lung cancer	0.000693	0.00124	CcSEcCtD
Mometasone—Angioedema—Paclitaxel—lung cancer	0.000693	0.00124	CcSEcCtD
Mometasone—Anaphylactic shock—Cisplatin—lung cancer	0.000689	0.00123	CcSEcCtD
Mometasone—Infection—Cisplatin—lung cancer	0.000684	0.00122	CcSEcCtD
Mometasone—Vomiting—Topotecan—lung cancer	0.000684	0.00122	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—CREBBP—lung cancer	0.000683	0.00486	CbGpPWpGaD
Mometasone—Paraesthesia—Irinotecan—lung cancer	0.000681	0.00122	CcSEcCtD
Mometasone—Rash—Topotecan—lung cancer	0.000678	0.00121	CcSEcCtD
Mometasone—Dermatitis—Topotecan—lung cancer	0.000677	0.00121	CcSEcCtD
Mometasone—Vomiting—Erlotinib—lung cancer	0.000676	0.00121	CcSEcCtD
Mometasone—Dyspnoea—Irinotecan—lung cancer	0.000676	0.00121	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—MMP1—lung cancer	0.000675	0.00481	CbGpPWpGaD
Mometasone—Cough—Etoposide—lung cancer	0.000675	0.0012	CcSEcCtD
Mometasone—Headache—Topotecan—lung cancer	0.000674	0.0012	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000673	0.0012	CcSEcCtD
Mometasone—Rash—Erlotinib—lung cancer	0.000671	0.0012	CcSEcCtD
Mometasone—Dermatitis—Erlotinib—lung cancer	0.00067	0.0012	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—HIF1A—lung cancer	0.000669	0.00477	CbGpPWpGaD
Mometasone—Dyspepsia—Irinotecan—lung cancer	0.000668	0.00119	CcSEcCtD
Mometasone—Immune system disorder—Docetaxel—lung cancer	0.000667	0.00119	CcSEcCtD
Mometasone—Headache—Erlotinib—lung cancer	0.000667	0.00119	CcSEcCtD
Mometasone—Mediastinal disorder—Docetaxel—lung cancer	0.000665	0.00119	CcSEcCtD
Mometasone—Asthma—Methotrexate—lung cancer	0.000665	0.00119	CcSEcCtD
Mometasone—Paraesthesia—Gemcitabine—lung cancer	0.000664	0.00118	CcSEcCtD
Mometasone—NR3C1—Circadian Clock—CREBBP—lung cancer	0.000663	0.00472	CbGpPWpGaD
Mometasone—Cough—Paclitaxel—lung cancer	0.000662	0.00118	CcSEcCtD
Mometasone—Asthenia—Vinorelbine—lung cancer	0.00066	0.00118	CcSEcCtD
Mometasone—Decreased appetite—Irinotecan—lung cancer	0.00066	0.00118	CcSEcCtD
Mometasone—Dyspnoea—Gemcitabine—lung cancer	0.000659	0.00118	CcSEcCtD
Mometasone—Chest pain—Etoposide—lung cancer	0.000658	0.00117	CcSEcCtD
Mometasone—Nausea—Vinblastine—lung cancer	0.000658	0.00117	CcSEcCtD
Mometasone—Anorexia—Cisplatin—lung cancer	0.000657	0.00117	CcSEcCtD
Mometasone—Fatigue—Irinotecan—lung cancer	0.000654	0.00117	CcSEcCtD
Mometasone—Pruritus—Vinorelbine—lung cancer	0.000651	0.00116	CcSEcCtD
Mometasone—Pain—Irinotecan—lung cancer	0.000649	0.00116	CcSEcCtD
Mometasone—Chest pain—Paclitaxel—lung cancer	0.000645	0.00115	CcSEcCtD
Mometasone—Myalgia—Paclitaxel—lung cancer	0.000645	0.00115	CcSEcCtD
Mometasone—Arthralgia—Paclitaxel—lung cancer	0.000645	0.00115	CcSEcCtD
Mometasone—Decreased appetite—Gemcitabine—lung cancer	0.000642	0.00115	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TF—lung cancer	0.000642	0.00457	CbGpPWpGaD
Mometasone—Nausea—Topotecan—lung cancer	0.000639	0.00114	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—CYP2A7—lung cancer	0.000637	0.00454	CbGpPWpGaD
Mometasone—Fatigue—Gemcitabine—lung cancer	0.000637	0.00114	CcSEcCtD
Mometasone—Pain—Gemcitabine—lung cancer	0.000632	0.00113	CcSEcCtD
Mometasone—Nausea—Erlotinib—lung cancer	0.000632	0.00113	CcSEcCtD
Mometasone—Dry mouth—Paclitaxel—lung cancer	0.000631	0.00113	CcSEcCtD
Mometasone—Anaphylactic shock—Etoposide—lung cancer	0.000631	0.00113	CcSEcCtD
Mometasone—Diarrhoea—Vinorelbine—lung cancer	0.000629	0.00112	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—CYP2A7—lung cancer	0.000629	0.00448	CbGpPWpGaD
Mometasone—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000628	0.00112	CcSEcCtD
Mometasone—Infection—Etoposide—lung cancer	0.000627	0.00112	CcSEcCtD
Mometasone—Back pain—Docetaxel—lung cancer	0.000622	0.00111	CcSEcCtD
Mometasone—Gastrointestinal pain—Irinotecan—lung cancer	0.00062	0.00111	CcSEcCtD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—lung cancer	0.00062	0.00442	CbGpPWpGaD
Mometasone—Anaphylactic shock—Paclitaxel—lung cancer	0.000619	0.0011	CcSEcCtD
Mometasone—Paraesthesia—Cisplatin—lung cancer	0.000619	0.0011	CcSEcCtD
Mometasone—Upper respiratory tract infection—Methotrexate—lung cancer	0.000618	0.0011	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—lung cancer	0.000616	0.00438	CbGpPWpGaD
Mometasone—Infection—Paclitaxel—lung cancer	0.000615	0.0011	CcSEcCtD
Mometasone—Dyspnoea—Cisplatin—lung cancer	0.000614	0.0011	CcSEcCtD
Mometasone—CYP2C8—Arachidonic acid metabolism—CYP1A1—lung cancer	0.000608	0.00433	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—APC—lung cancer	0.000604	0.0043	CbGpPWpGaD
Mometasone—Anorexia—Etoposide—lung cancer	0.000602	0.00107	CcSEcCtD
Mometasone—Body temperature increased—Irinotecan—lung cancer	0.0006	0.00107	CcSEcCtD
Mometasone—Abdominal pain—Irinotecan—lung cancer	0.0006	0.00107	CcSEcCtD
Mometasone—Decreased appetite—Cisplatin—lung cancer	0.000599	0.00107	CcSEcCtD
Mometasone—Nasopharyngitis—Doxorubicin—lung cancer	0.000596	0.00106	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—lung cancer	0.000595	0.00424	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000593	0.00422	CbGpPWpGaD
Mometasone—Anorexia—Paclitaxel—lung cancer	0.00059	0.00105	CcSEcCtD
Mometasone—Pain—Cisplatin—lung cancer	0.000589	0.00105	CcSEcCtD
Mometasone—Vomiting—Vinorelbine—lung cancer	0.000585	0.00104	CcSEcCtD
Mometasone—Body temperature increased—Gemcitabine—lung cancer	0.000584	0.00104	CcSEcCtD
Mometasone—Hydrocortisone—ABCG2—lung cancer	0.000583	0.0354	CrCbGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—MDM2—lung cancer	0.00058	0.00413	CbGpPWpGaD
Mometasone—Rash—Vinorelbine—lung cancer	0.00058	0.00103	CcSEcCtD
Mometasone—Dermatitis—Vinorelbine—lung cancer	0.000579	0.00103	CcSEcCtD
Mometasone—Headache—Vinorelbine—lung cancer	0.000576	0.00103	CcSEcCtD
Mometasone—Conjunctivitis—Methotrexate—lung cancer	0.000576	0.00103	CcSEcCtD
Mometasone—Influenza—Doxorubicin—lung cancer	0.000576	0.00103	CcSEcCtD
Mometasone—Asthma—Doxorubicin—lung cancer	0.000576	0.00103	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GSTA3—lung cancer	0.000568	0.00405	CbGpPWpGaD
Mometasone—Paraesthesia—Etoposide—lung cancer	0.000567	0.00101	CcSEcCtD
Mometasone—Fluticasone furoate—ABCB1—lung cancer	0.000565	0.0342	CrCbGaD
Mometasone—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000564	0.00101	CcSEcCtD
Mometasone—Dyspnoea—Etoposide—lung cancer	0.000563	0.001	CcSEcCtD
Mometasone—Cough—Docetaxel—lung cancer	0.000561	0.001	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—GSTA3—lung cancer	0.00056	0.00399	CbGpPWpGaD
Mometasone—Epistaxis—Methotrexate—lung cancer	0.000559	0.000997	CcSEcCtD
Mometasone—Paraesthesia—Paclitaxel—lung cancer	0.000556	0.000991	CcSEcCtD
Mometasone—Bronchitis—Doxorubicin—lung cancer	0.000554	0.000988	CcSEcCtD
Mometasone—Dyspnoea—Paclitaxel—lung cancer	0.000552	0.000984	CcSEcCtD
Mometasone—Decreased appetite—Etoposide—lung cancer	0.000549	0.000979	CcSEcCtD
Mometasone—Myalgia—Docetaxel—lung cancer	0.000547	0.000976	CcSEcCtD
Mometasone—Arthralgia—Docetaxel—lung cancer	0.000547	0.000976	CcSEcCtD
Mometasone—Chest pain—Docetaxel—lung cancer	0.000547	0.000976	CcSEcCtD
Mometasone—Nausea—Vinorelbine—lung cancer	0.000546	0.000975	CcSEcCtD
Mometasone—Dyspepsia—Paclitaxel—lung cancer	0.000545	0.000972	CcSEcCtD
Mometasone—Body temperature increased—Cisplatin—lung cancer	0.000545	0.000971	CcSEcCtD
Mometasone—Asthenia—Irinotecan—lung cancer	0.000544	0.000971	CcSEcCtD
Mometasone—Fatigue—Etoposide—lung cancer	0.000544	0.000971	CcSEcCtD
Mometasone—Pain—Etoposide—lung cancer	0.00054	0.000963	CcSEcCtD
Mometasone—Decreased appetite—Paclitaxel—lung cancer	0.000538	0.00096	CcSEcCtD
Mometasone—Dry mouth—Docetaxel—lung cancer	0.000535	0.000955	CcSEcCtD
Mometasone—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000535	0.000954	CcSEcCtD
Mometasone—Fatigue—Paclitaxel—lung cancer	0.000533	0.000952	CcSEcCtD
Mometasone—Asthenia—Gemcitabine—lung cancer	0.00053	0.000946	CcSEcCtD
Mometasone—Pain—Paclitaxel—lung cancer	0.000529	0.000944	CcSEcCtD
Mometasone—Pharyngitis—Methotrexate—lung cancer	0.000528	0.000942	CcSEcCtD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000525	0.00374	CbGpPWpGaD
Mometasone—Anaphylactic shock—Docetaxel—lung cancer	0.000524	0.000936	CcSEcCtD
Mometasone—Pruritus—Gemcitabine—lung cancer	0.000523	0.000933	CcSEcCtD
Mometasone—Infection—Docetaxel—lung cancer	0.000521	0.00093	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GSTA4—lung cancer	0.00052	0.0037	CbGpPWpGaD
Mometasone—Diarrhoea—Irinotecan—lung cancer	0.000519	0.000926	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000518	0.00369	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Etoposide—lung cancer	0.000516	0.000921	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—GSTA4—lung cancer	0.000512	0.00365	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTA2—lung cancer	0.000506	0.00361	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000506	0.000903	CcSEcCtD
Mometasone—Diarrhoea—Gemcitabine—lung cancer	0.000506	0.000902	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—JUN—lung cancer	0.000504	0.00359	CbGpPWpGaD
Mometasone—Anorexia—Docetaxel—lung cancer	0.0005	0.000892	CcSEcCtD
Mometasone—Abdominal pain—Etoposide—lung cancer	0.000499	0.00089	CcSEcCtD
Mometasone—Body temperature increased—Etoposide—lung cancer	0.000499	0.00089	CcSEcCtD
Mometasone—Urinary tract infection—Doxorubicin—lung cancer	0.000499	0.00089	CcSEcCtD
Mometasone—Conjunctivitis—Doxorubicin—lung cancer	0.000499	0.00089	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—lung cancer	0.000495	0.00352	CbGpPWpGaD
Mometasone—Asthenia—Cisplatin—lung cancer	0.000494	0.000882	CcSEcCtD
Mometasone—Abdominal pain—Paclitaxel—lung cancer	0.000489	0.000873	CcSEcCtD
Mometasone—Body temperature increased—Paclitaxel—lung cancer	0.000489	0.000873	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GSTA1—lung cancer	0.000489	0.00348	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—lung cancer	0.000487	0.00346	CbGpPWpGaD
Mometasone—Dexamethasone—CYP2A6—lung cancer	0.000486	0.0295	CrCbGaD
Mometasone—Epistaxis—Doxorubicin—lung cancer	0.000484	0.000864	CcSEcCtD
Mometasone—Vomiting—Irinotecan—lung cancer	0.000482	0.000861	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—lung cancer	0.000482	0.00343	CbGpPWpGaD
Mometasone—Sinusitis—Doxorubicin—lung cancer	0.000481	0.000859	CcSEcCtD
Mometasone—Immune system disorder—Methotrexate—lung cancer	0.000481	0.000857	CcSEcCtD
Mometasone—Mediastinal disorder—Methotrexate—lung cancer	0.00048	0.000855	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN2A—lung cancer	0.000479	0.00341	CbGpPWpGaD
Mometasone—Rash—Irinotecan—lung cancer	0.000478	0.000853	CcSEcCtD
Mometasone—Dermatitis—Irinotecan—lung cancer	0.000478	0.000853	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000478	0.000852	CcSEcCtD
Mometasone—Headache—Irinotecan—lung cancer	0.000475	0.000848	CcSEcCtD
Mometasone—Diarrhoea—Cisplatin—lung cancer	0.000471	0.000841	CcSEcCtD
Mometasone—Paraesthesia—Docetaxel—lung cancer	0.000471	0.00084	CcSEcCtD
Mometasone—Vomiting—Gemcitabine—lung cancer	0.00047	0.000838	CcSEcCtD
Mometasone—Dyspnoea—Docetaxel—lung cancer	0.000468	0.000834	CcSEcCtD
Mometasone—Rash—Gemcitabine—lung cancer	0.000466	0.000831	CcSEcCtD
Mometasone—Dermatitis—Gemcitabine—lung cancer	0.000466	0.000831	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—EP300—lung cancer	0.000465	0.00331	CbGpPWpGaD
Mometasone—Headache—Gemcitabine—lung cancer	0.000463	0.000826	CcSEcCtD
Mometasone—Rhinitis—Doxorubicin—lung cancer	0.000462	0.000824	CcSEcCtD
Mometasone—Dyspepsia—Docetaxel—lung cancer	0.000462	0.000824	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—AKR1C1—lung cancer	0.000461	0.00329	CbGpPWpGaD
Mometasone—Pharyngitis—Doxorubicin—lung cancer	0.000457	0.000816	CcSEcCtD
Mometasone—Decreased appetite—Docetaxel—lung cancer	0.000456	0.000813	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—UGT1A1—lung cancer	0.000454	0.00323	CbGpPWpGaD
Mometasone—Asthenia—Etoposide—lung cancer	0.000453	0.000808	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.000452	0.00322	CbGpPWpGaD
Mometasone—Fatigue—Docetaxel—lung cancer	0.000452	0.000807	CcSEcCtD
Mometasone—NR3C1—Circadian Clock—EP300—lung cancer	0.000452	0.00322	CbGpPWpGaD
Mometasone—Nausea—Irinotecan—lung cancer	0.000451	0.000804	CcSEcCtD
Mometasone—Methylprednisolone—ABCB1—lung cancer	0.00045	0.0273	CrCbGaD
Mometasone—Pain—Docetaxel—lung cancer	0.000448	0.0008	CcSEcCtD
Mometasone—Back pain—Methotrexate—lung cancer	0.000448	0.000799	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—UGT1A1—lung cancer	0.000448	0.00319	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000447	0.00318	CbGpPWpGaD
Mometasone—Pruritus—Etoposide—lung cancer	0.000446	0.000797	CcSEcCtD
Mometasone—Triamcinolone—PTGS2—lung cancer	0.000446	0.0271	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.000445	0.00317	CbGpPWpGaD
Mometasone—Asthenia—Paclitaxel—lung cancer	0.000444	0.000792	CcSEcCtD
Mometasone—Nausea—Gemcitabine—lung cancer	0.000439	0.000783	CcSEcCtD
Mometasone—Vomiting—Cisplatin—lung cancer	0.000438	0.000781	CcSEcCtD
Mometasone—Pruritus—Paclitaxel—lung cancer	0.000438	0.000781	CcSEcCtD
Mometasone—Dexamethasone—ABCG2—lung cancer	0.000434	0.0263	CrCbGaD
Mometasone—Rash—Cisplatin—lung cancer	0.000434	0.000775	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.000434	0.00309	CbGpPWpGaD
Mometasone—Dermatitis—Cisplatin—lung cancer	0.000434	0.000774	CcSEcCtD
Mometasone—Diarrhoea—Etoposide—lung cancer	0.000432	0.00077	CcSEcCtD
Mometasone—Gastrointestinal pain—Docetaxel—lung cancer	0.000429	0.000765	CcSEcCtD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000426	0.00303	CbGpPWpGaD
Mometasone—Diarrhoea—Paclitaxel—lung cancer	0.000423	0.000755	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.000421	0.003	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.000418	0.00298	CbGpPWpGaD
Mometasone—Immune system disorder—Doxorubicin—lung cancer	0.000416	0.000742	CcSEcCtD
Mometasone—Mediastinal disorder—Doxorubicin—lung cancer	0.000415	0.000741	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.000415	0.00296	CbGpPWpGaD
Mometasone—Abdominal pain—Docetaxel—lung cancer	0.000415	0.00074	CcSEcCtD
Mometasone—Body temperature increased—Docetaxel—lung cancer	0.000415	0.00074	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.000409	0.00291	CbGpPWpGaD
Mometasone—Nausea—Cisplatin—lung cancer	0.000409	0.00073	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—HIF1A—lung cancer	0.000408	0.0029	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.000408	0.0029	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.000405	0.00288	CbGpPWpGaD
Mometasone—Cough—Methotrexate—lung cancer	0.000404	0.000721	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.000404	0.00287	CbGpPWpGaD
Mometasone—Vomiting—Etoposide—lung cancer	0.000401	0.000716	CcSEcCtD
Mometasone—Rash—Etoposide—lung cancer	0.000398	0.00071	CcSEcCtD
Mometasone—Dermatitis—Etoposide—lung cancer	0.000398	0.000709	CcSEcCtD
Mometasone—Headache—Etoposide—lung cancer	0.000395	0.000705	CcSEcCtD
Mometasone—Myalgia—Methotrexate—lung cancer	0.000394	0.000703	CcSEcCtD
Mometasone—Chest pain—Methotrexate—lung cancer	0.000394	0.000703	CcSEcCtD
Mometasone—Arthralgia—Methotrexate—lung cancer	0.000394	0.000703	CcSEcCtD
Mometasone—Vomiting—Paclitaxel—lung cancer	0.000393	0.000702	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.000393	0.0028	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000392	0.00279	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.00039	0.00278	CbGpPWpGaD
Mometasone—Rash—Paclitaxel—lung cancer	0.00039	0.000696	CcSEcCtD
Mometasone—Dermatitis—Paclitaxel—lung cancer	0.00039	0.000695	CcSEcCtD
Mometasone—Back pain—Doxorubicin—lung cancer	0.000388	0.000692	CcSEcCtD
Mometasone—Headache—Paclitaxel—lung cancer	0.000388	0.000692	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—HPGDS—lung cancer	0.000386	0.00275	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.000383	0.00272	CbGpPWpGaD
Mometasone—Anaphylactic shock—Methotrexate—lung cancer	0.000378	0.000674	CcSEcCtD
Mometasone—Asthenia—Docetaxel—lung cancer	0.000376	0.000671	CcSEcCtD
Mometasone—Infection—Methotrexate—lung cancer	0.000376	0.00067	CcSEcCtD
Mometasone—Nausea—Etoposide—lung cancer	0.000375	0.000669	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GSTT1—lung cancer	0.000375	0.00267	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.000372	0.00265	CbGpPWpGaD
Mometasone—Pruritus—Docetaxel—lung cancer	0.000371	0.000662	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GCLC—lung cancer	0.00037	0.00264	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP2A6—lung cancer	0.00037	0.00264	CbGpPWpGaD
Mometasone—Nausea—Paclitaxel—lung cancer	0.000368	0.000656	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.000366	0.0026	CbGpPWpGaD
Mometasone—Betamethasone—PTGS2—lung cancer	0.000366	0.0222	CrCbGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—PTGS2—lung cancer	0.000361	0.00257	CbGpPWpGaD
Mometasone—Prednisone—ALB—lung cancer	0.000361	0.0219	CrCbGaD
Mometasone—Anorexia—Methotrexate—lung cancer	0.00036	0.000643	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000359	0.00256	CbGpPWpGaD
Mometasone—Diarrhoea—Docetaxel—lung cancer	0.000359	0.00064	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.000356	0.00253	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—EIF2B4—lung cancer	0.000353	0.00251	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000353	0.00251	CbGpPWpGaD
Mometasone—Cough—Doxorubicin—lung cancer	0.00035	0.000624	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.000348	0.00248	CbGpPWpGaD
Mometasone—Dexamethasone—CYP2E1—lung cancer	0.000345	0.0209	CrCbGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	0.000345	0.00246	CbGpPWpGaD
Mometasone—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000344	0.000614	CcSEcCtD
Mometasone—Prednisone—ABCB1—lung cancer	0.000344	0.0209	CrCbGaD
Mometasone—Arthralgia—Doxorubicin—lung cancer	0.000341	0.000609	CcSEcCtD
Mometasone—Myalgia—Doxorubicin—lung cancer	0.000341	0.000609	CcSEcCtD
Mometasone—Chest pain—Doxorubicin—lung cancer	0.000341	0.000609	CcSEcCtD
Mometasone—Dexamethasone—CYP1A1—lung cancer	0.00034	0.0206	CrCbGaD
Mometasone—Paraesthesia—Methotrexate—lung cancer	0.000339	0.000606	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000339	0.00241	CbGpPWpGaD
Mometasone—Dyspnoea—Methotrexate—lung cancer	0.000337	0.000601	CcSEcCtD
Mometasone—Dry mouth—Doxorubicin—lung cancer	0.000334	0.000596	CcSEcCtD
Mometasone—Vomiting—Docetaxel—lung cancer	0.000333	0.000595	CcSEcCtD
Mometasone—Dyspepsia—Methotrexate—lung cancer	0.000333	0.000594	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—RB1—lung cancer	0.000332	0.00236	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000331	0.00236	CbGpPWpGaD
Mometasone—Rash—Docetaxel—lung cancer	0.000331	0.00059	CcSEcCtD
Mometasone—Dermatitis—Docetaxel—lung cancer	0.00033	0.000589	CcSEcCtD
Mometasone—Decreased appetite—Methotrexate—lung cancer	0.000329	0.000586	CcSEcCtD
Mometasone—Headache—Docetaxel—lung cancer	0.000329	0.000586	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.000328	0.00234	CbGpPWpGaD
Mometasone—Anaphylactic shock—Doxorubicin—lung cancer	0.000327	0.000584	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.000327	0.00233	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000326	0.00232	CbGpPWpGaD
Mometasone—Fatigue—Methotrexate—lung cancer	0.000326	0.000581	CcSEcCtD
Mometasone—Infection—Doxorubicin—lung cancer	0.000325	0.00058	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.000324	0.00231	CbGpPWpGaD
Mometasone—Pain—Methotrexate—lung cancer	0.000323	0.000577	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.000319	0.00227	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000317	0.00226	CbGpPWpGaD
Mometasone—Prednisolone—ABCB1—lung cancer	0.000317	0.0192	CrCbGaD
Mometasone—CYP2C8—Biological oxidations—CYP2E1—lung cancer	0.000315	0.00224	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.000314	0.00224	CbGpPWpGaD
Mometasone—Anorexia—Doxorubicin—lung cancer	0.000312	0.000557	CcSEcCtD
Mometasone—Nausea—Docetaxel—lung cancer	0.000312	0.000556	CcSEcCtD
Mometasone—Betamethasone—ABCB1—lung cancer	0.000311	0.0188	CrCbGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP2E1—lung cancer	0.00031	0.00221	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Methotrexate—lung cancer	0.000309	0.000551	CcSEcCtD
Mometasone—Abdominal pain—Methotrexate—lung cancer	0.000299	0.000533	CcSEcCtD
Mometasone—Body temperature increased—Methotrexate—lung cancer	0.000299	0.000533	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000298	0.000532	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	0.000294	0.00209	CbGpPWpGaD
Mometasone—Paraesthesia—Doxorubicin—lung cancer	0.000294	0.000524	CcSEcCtD
Mometasone—Dyspnoea—Doxorubicin—lung cancer	0.000292	0.000521	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000289	0.00206	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000288	0.00205	CbGpPWpGaD
Mometasone—Dyspepsia—Doxorubicin—lung cancer	0.000288	0.000514	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000288	0.00205	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—KHSRP—lung cancer	0.000288	0.00205	CbGpPWpGaD
Mometasone—Decreased appetite—Doxorubicin—lung cancer	0.000285	0.000508	CcSEcCtD
Mometasone—Fatigue—Doxorubicin—lung cancer	0.000282	0.000503	CcSEcCtD
Mometasone—Pain—Doxorubicin—lung cancer	0.00028	0.000499	CcSEcCtD
Mometasone—Asthenia—Methotrexate—lung cancer	0.000271	0.000484	CcSEcCtD
Mometasone—Gastrointestinal pain—Doxorubicin—lung cancer	0.000268	0.000478	CcSEcCtD
Mometasone—Pruritus—Methotrexate—lung cancer	0.000267	0.000477	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—TP53—lung cancer	0.000266	0.0019	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000263	0.00187	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTP1—lung cancer	0.00026	0.00185	CbGpPWpGaD
Mometasone—Abdominal pain—Doxorubicin—lung cancer	0.000259	0.000462	CcSEcCtD
Mometasone—Body temperature increased—Doxorubicin—lung cancer	0.000259	0.000462	CcSEcCtD
Mometasone—Diarrhoea—Methotrexate—lung cancer	0.000259	0.000461	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—GSTP1—lung cancer	0.000256	0.00182	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—EIF2B5—lung cancer	0.000251	0.00179	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—lung cancer	0.000244	0.00174	CbGpPWpGaD
Mometasone—Hydrocortisone—ABCB1—lung cancer	0.000243	0.0147	CrCbGaD
Mometasone—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	0.000242	0.00172	CbGpPWpGaD
Mometasone—Vomiting—Methotrexate—lung cancer	0.00024	0.000429	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GSTM1—lung cancer	0.000239	0.0017	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CDKN1A—lung cancer	0.000239	0.0017	CbGpPWpGaD
Mometasone—Rash—Methotrexate—lung cancer	0.000238	0.000425	CcSEcCtD
Mometasone—Dermatitis—Methotrexate—lung cancer	0.000238	0.000425	CcSEcCtD
Mometasone—Headache—Methotrexate—lung cancer	0.000237	0.000422	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—GSTM1—lung cancer	0.000235	0.00168	CbGpPWpGaD
Mometasone—Asthenia—Doxorubicin—lung cancer	0.000235	0.000419	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	0.000235	0.00167	CbGpPWpGaD
Mometasone—Pruritus—Doxorubicin—lung cancer	0.000232	0.000413	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	0.000229	0.00163	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000229	0.00163	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—DICER1—lung cancer	0.000227	0.00162	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP1A1—lung cancer	0.000226	0.00161	CbGpPWpGaD
Mometasone—Nausea—Methotrexate—lung cancer	0.000225	0.000401	CcSEcCtD
Mometasone—Diarrhoea—Doxorubicin—lung cancer	0.000224	0.0004	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—CYP1A1—lung cancer	0.000223	0.00159	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000219	0.00156	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	0.000215	0.00153	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—STAT3—lung cancer	0.000213	0.00152	CbGpPWpGaD
Mometasone—Dexamethasone—PTGS2—lung cancer	0.000213	0.0129	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000213	0.00151	CbGpPWpGaD
Mometasone—Vomiting—Doxorubicin—lung cancer	0.000208	0.000371	CcSEcCtD
Mometasone—Rash—Doxorubicin—lung cancer	0.000206	0.000368	CcSEcCtD
Mometasone—Dermatitis—Doxorubicin—lung cancer	0.000206	0.000368	CcSEcCtD
Mometasone—Headache—Doxorubicin—lung cancer	0.000205	0.000366	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.0002	0.00143	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—COL4A3BP—lung cancer	0.000199	0.00142	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AZIN2—lung cancer	0.000199	0.00142	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	0.000198	0.00141	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SKI—lung cancer	0.000196	0.0014	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000196	0.0014	CbGpPWpGaD
Mometasone—Nausea—Doxorubicin—lung cancer	0.000194	0.000347	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000186	0.00132	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000185	0.00132	CbGpPWpGaD
Mometasone—Dexamethasone—ABCB1—lung cancer	0.000181	0.011	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.00018	0.00128	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ATP5H—lung cancer	0.000169	0.0012	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—POMC—lung cancer	0.000169	0.0012	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—RARB—lung cancer	0.000158	0.00112	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000155	0.00111	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NPPA—lung cancer	0.000154	0.00109	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PLBD1—lung cancer	0.000151	0.00107	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—lung cancer	0.000149	0.00106	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000148	0.00106	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD17B10—lung cancer	0.000138	0.000982	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HSPB1—lung cancer	0.000132	0.00094	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000128	0.000915	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CKB—lung cancer	0.000128	0.000913	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	0.000122	0.000866	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CNDP2—lung cancer	0.000121	0.000858	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTM2—lung cancer	0.000121	0.000858	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTMR3—lung cancer	0.000117	0.000835	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NOTCH3—lung cancer	0.000116	0.000829	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PGAM1—lung cancer	0.000114	0.000814	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—JUNB—lung cancer	0.00011	0.000785	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2A7—lung cancer	0.000109	0.000776	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SDC4—lung cancer	0.000107	0.00076	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—RRM1—lung cancer	9.72e-05	0.000692	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA3—lung cancer	9.72e-05	0.000692	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—B4GALT5—lung cancer	9.13e-05	0.00065	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA4—lung cancer	8.89e-05	0.000633	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	8.68e-05	0.000618	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA2—lung cancer	8.66e-05	0.000617	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA1—lung cancer	8.35e-05	0.000595	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCC3—lung cancer	8.26e-05	0.000588	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKR1C1—lung cancer	8e-05	0.00057	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ERCC2—lung cancer	8e-05	0.00057	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UGT1A1—lung cancer	7.77e-05	0.000553	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GNG11—lung cancer	7.49e-05	0.000533	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	7.45e-05	0.000531	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—MYC—lung cancer	7.22e-05	0.000514	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALDOA—lung cancer	7.13e-05	0.000508	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NCOA3—lung cancer	6.92e-05	0.000493	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.8e-05	0.000484	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ADCY1—lung cancer	6.73e-05	0.00048	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCG2—lung cancer	6.73e-05	0.00048	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ENO2—lung cancer	6.6e-05	0.00047	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HPGDS—lung cancer	6.6e-05	0.00047	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPP2R1B—lung cancer	6.56e-05	0.000467	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.48e-05	0.000461	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTT1—lung cancer	6.41e-05	0.000456	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2A6—lung cancer	6.33e-05	0.000451	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GCLC—lung cancer	6.33e-05	0.000451	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.31e-05	0.000449	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ENO1—lung cancer	6e-05	0.000427	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.98e-05	0.000426	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.9e-05	0.00042	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CREBBP—lung cancer	5.86e-05	0.000417	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2E1—lung cancer	5.38e-05	0.000383	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NQO1—lung cancer	5.32e-05	0.000379	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.21e-05	0.000371	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.16e-05	0.000368	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—STK11—lung cancer	4.8e-05	0.000342	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.5e-05	0.000321	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTP1—lung cancer	4.44e-05	0.000316	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CAT—lung cancer	4.32e-05	0.000308	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.3e-05	0.000306	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCB1—lung cancer	4.2e-05	0.000299	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TYMS—lung cancer	4.13e-05	0.000294	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTM1—lung cancer	4.08e-05	0.000291	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP1A1—lung cancer	3.87e-05	0.000275	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ERCC2—lung cancer	3.84e-05	0.000273	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MAPK3—lung cancer	3.57e-05	0.000255	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MYC—lung cancer	3.48e-05	0.000248	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOA1—lung cancer	3.32e-05	0.000236	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.18e-05	0.000226	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CG—lung cancer	3.03e-05	0.000216	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—POMC—lung cancer	2.88e-05	0.000205	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CREBBP—lung cancer	2.81e-05	0.0002	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CD—lung cancer	2.66e-05	0.00019	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALB—lung cancer	2.63e-05	0.000187	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AKT1—lung cancer	2.41e-05	0.000172	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CB—lung cancer	2.32e-05	0.000165	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGS2—lung cancer	2.3e-05	0.000164	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTEN—lung cancer	2.01e-05	0.000143	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—EP300—lung cancer	1.91e-05	0.000136	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CA—lung cancer	1.42e-05	0.000101	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKT1—lung cancer	1.16e-05	8.23e-05	CbGpPWpGaD
